NiPPeR Randomised Trial - Child Follow Up Study

NCT ID: NCT05934422

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

461 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-16

Study Completion Date

2025-08-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is an increasing focus on the need to optimise nutrition, lifestyle and metabolism of parents before and during pregnancy and of the infant after birth, but as yet there is limited understanding of the specific influences and of the underlying mechanisms.

This study is a follow up of children from the NiPPeR trial of a nutritional drink enriched with micronutrients, myo-inositol and probiotics taken preconception and during pregnancy. In this setting we will examine the influence of parental nutrition, lifestyle and metabolism before and during pregnancy on child growth, development and well-being; ascertaining growth, adiposity, metabolism, neurobehavioural and health outcomes in the children, and characterising the underlying mechanisms.

The data collected will allow identification of the contributions of parental and offspring characteristics, nutritional, lifestyle and medical factors, social and economic status, ethnicity, genetics, metabolism and microbes to promoting healthy growth, body composition and wellbeing in the children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis Atopy Nutrition, Healthy Lifestyle Microbial Colonization Breastfeeding Obesity, Childhood Cognition Neurobehavioral Manifestations Metabolic Disturbance Growth Disorders Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prior Intervention - enhanced micronutrients, probiotics, myo-inositol in preconception & pregnancy

NiPPeR Study intervention drink containing a mix of micronutrients, probiotics and myo-inositol given to the mother during preconception \& pregnancy

Group Type EXPERIMENTAL

Intervention (Study Nutritional Drink)

Intervention Type OTHER

Study nutritional drink containing a mix of enriched micronutrients, probiotics and myo-inositol.

Prior Control - standard micronutrients in preconception & pregnancy

NiPPeR Study control nutritional drink containing a mix of micronutrients given to the mother during preconception \& pregnancy

Group Type ACTIVE_COMPARATOR

Control (Standard Nutritional Drink)

Intervention Type OTHER

Control nutritional drink containing a standard mix of micronutrients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention (Study Nutritional Drink)

Study nutritional drink containing a mix of enriched micronutrients, probiotics and myo-inositol.

Intervention Type OTHER

Control (Standard Nutritional Drink)

Control nutritional drink containing a standard mix of micronutrients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All children still participating in the NiPPeR study at 6-8 years.

Exclusion Criteria

Known significant congenital anomaly or genetic condition that influences child growth or neurodevelopment.
Minimum Eligible Age

6 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National University Hospital, Singapore

OTHER

Sponsor Role collaborator

Auckland UniServices Ltd.

INDUSTRY

Sponsor Role collaborator

Institute for Human Development and Potential (IHDP), Singapore

OTHER

Sponsor Role collaborator

National University of Singapore

OTHER

Sponsor Role collaborator

National University Health System, Singapore

OTHER

Sponsor Role collaborator

University of Auckland, New Zealand

OTHER

Sponsor Role collaborator

University of Southampton

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wayne S Cutfield, MB MD FRACP

Role: PRINCIPAL_INVESTIGATOR

The University of Auckland

Shiao-Yng Chan, MD PhD FRCOG

Role: PRINCIPAL_INVESTIGATOR

National University of Singapore

Keith M Godfrey, BM PhD FRCP

Role: PRINCIPAL_INVESTIGATOR

MRC Lifecourse Epidemiology Centre, University of Southampton

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Auckland

Auckland, , New Zealand

Site Status

National University Hospital

Singapore, , Singapore

Site Status

University Hospital Southampton

Southampton, Hampshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Zealand Singapore United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Godfrey KM, Cutfield W, Chan SY, Baker PN, Chong YS; NiPPeR Study Group. Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health ("NiPPeR"): study protocol for a randomised controlled trial. Trials. 2017 Mar 20;18(1):131. doi: 10.1186/s13063-017-1875-x.

Reference Type BACKGROUND
PMID: 28320484 (View on PubMed)

Godfrey KM, Barton SJ, El-Heis S, Kenealy T, Nield H, Baker PN, Chong YS, Cutfield W, Chan SY; NiPPeR Study Group. Myo-Inositol, Probiotics, and Micronutrient Supplementation From Preconception for Glycemia in Pregnancy: NiPPeR International Multicenter Double-Blind Randomized Controlled Trial. Diabetes Care. 2021 May;44(5):1091-1099. doi: 10.2337/dc20-2515. Epub 2021 Mar 29.

Reference Type BACKGROUND
PMID: 33782086 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

79093

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Healthy Infant Development Project
NCT00613717 COMPLETED NA